Science
Episode 61: Dr. Lance Wells on Glycobiology
In Episode 61 of Let's Talk Chemistry, Dr. Lance Wells discusses the critical role of glycobiology in understanding diseases and developing therapeutics. He shares insights from his research at t...
Episode 61: Dr. Lance Wells on Glycobiology
Science •
0:00 / 0:00
Interactive Transcript
spk_0
Hi, you're listening to Let's Talk Chemistry, a podcast by Chem Talk.
spk_0
On today's episode, we interview Dr. Lance Wells, professor of biochemistry and molecular
spk_0
biology at the University of Georgia and associate director of the Complex Carbohydrate
spk_0
Research Center.
spk_0
Dr. Wells researches how disregulation of glycosylation can consume you to disease, as
spk_0
well as how glycans can be used to develop more effective treatments.
spk_0
He also shares how working with families affected by these diseases have shaped his research,
spk_0
inspiring him to focus on real real translational impact.
spk_0
We hope you enjoy.
spk_0
Hi, and welcome to another episode of Let's Talk Chemistry.
spk_0
My name is Jasmine.
spk_0
My name is Dia, and my name is Eric.
spk_0
Today we are sharing with you the story of Dr. Lance Wells, a professor of biochemistry
spk_0
and molecular biology at the University of Georgia, who also happens to be my research
spk_0
mentor.
spk_0
He also serves as the president of the annual Society for Glicobiology, leads a research
spk_0
lab and is the associate director of the Complex Carbohydrate Research Center, or the
spk_0
CCRC.
spk_0
His college education began as an undergraduate at Georgia Tech in Chemistry, where he worked
spk_0
for a couple years in a lab and really enjoyed bench work.
spk_0
This led him to pursue a PhD in biochemistry and molecular biology at Emory University.
spk_0
During his PhD, Dr. Wells conducted a postdoc at Johns Hopkins School of Medicine, and
spk_0
this provided the necessary medical background for the research he does today at the CCRC.
spk_0
The CCRC is made up of 16 to 17 labs completely dedicated to the study of carbohydrates, and
spk_0
his lab has a human disease focus.
spk_0
There's four major biomolecules of life.
spk_0
I think most people know the DNA RNA protein, right?
spk_0
So the nucleic acid and protein, that's two of the four molecules of life, because the
spk_0
other two that are essential for life are lipids or fats and are carbohydrates.
spk_0
When we say carbohydrates, I think most people think things to avoid eating and shudder
spk_0
things that make things sweet.
spk_0
What we're talking about is large polymers, some of them small polymers, that are attached
spk_0
to either lipids or they can be attached to proteins, most commonly is what my lab
spk_0
studies, or they can even be attached to nucleic acids we know now.
spk_0
They can actually be attached to the other three molecules, and they affect function, and
spk_0
they can work independently.
spk_0
And so like on the second floor here, I'm up on the third floor, where we're all animal,
spk_0
we all work on some type of animal or human disease, on the second floor or the plant
spk_0
people, and they're studying the plants on wall, right, which is heavily has a lot of
spk_0
polyperinit.
spk_0
Glicobiology used to be underappreciated field, but in recent years it has garnered much
spk_0
more attention.
spk_0
Thanks to the efforts from scientists like Dr. Wells and institutions like the CCRC that
spk_0
are spearheading this initiative.
spk_0
So how did it all begin?
spk_0
Well, Dr. Wells started out at the CCRC researching a small glycan modification called Oglic
spk_0
NAC, which stands for O-linked beta-N acetyl glucosamine.
spk_0
This may sound complicated, but really it's just a sugar.
spk_0
Beta-N acetyl glucosamine, or GlicNAC, attached to a protein via an oxygen atom, specifically
spk_0
on the amino acids, serine or three inine.
spk_0
Together, the glycan and protein are referred to as a glycoprotein.
spk_0
That makes a lot of sense, but what makes OglicNAC so special?
spk_0
I wonder what drew Dr. Wells to study this particular modification?
spk_0
Great question, DIA, that leads us perfectly into hearing Dr. Wells share what sparked
spk_0
to scientific curiosity about OglicNAC and why it has become such a key focus of his
spk_0
research.
spk_0
When I first set up my lab, I was working on a really small modification called OglicNAC.
spk_0
So it's just a single sugar that gets added to nuclear and cytosolic proteins.
spk_0
So usually when you think glycoproteins, you think proteins are going to go through
spk_0
the secretory and pathway and either end up on the plasma membrane or be secreted
spk_0
from cells.
spk_0
But it turns out, and that's where we thought all sugars were up until the mid-1980s in
spk_0
terms of glycoproteins, but then Jerry Hart, who's where I went and did my postdoc, his
spk_0
lab had discovered that there was sugar on just a single sugar on nuclear and cytosolic
spk_0
proteins.
spk_0
And so my lab studied that for many years.
spk_0
What really kind of bumped that research up in our lab in the last 10 years was about
spk_0
10 years ago now.
spk_0
We had a geneticist reach out to us who had a family with three affected males with intellectual
spk_0
disability and they all had a mutation in the enzyme that puts that sugar on.
spk_0
It's called OGT.
spk_0
And so we got really interested in that obviously because this is an enzyme we've been studying
spk_0
for a long time.
spk_0
We started with one family that we characterized biochemically and published.
spk_0
The latest is about 75 families now with mutations in OGT.
spk_0
And so it's an intellectual disability syndrome.
spk_0
And we're actually two weeks from tomorrow, on November 9th, we're having the first annual
spk_0
OGT X-Length ID meeting.
spk_0
And that's going to have physician, scientist, but also families.
spk_0
The affected individuals get us all together and trying to figure out, you know, what can
spk_0
we do, how can we help move the field for?
spk_0
Wow.
spk_0
It's incredible how Dr. Wells research is driven by real patients who could benefit from
spk_0
his lab's discoveries.
spk_0
That kind of direct impact must be so motivating.
spk_0
Absolutely.
spk_0
And what's even more impressive is the sheer breadth of research happening in Dr. Wells
spk_0
lab.
spk_0
Beyond their work on Oak Lake NAC and its role in X-L-I-Ds, they're also investigating
spk_0
congenital muscular dystrophy and many other diseases with the power of mass spectrometry.
spk_0
A lot of my lab studies congenital muscular dystrophy.
spk_0
And so congenital muscular dystrophy, unlike say like the Shins muscular dystrophy, which
spk_0
is the most common form, congenital muscular dystrophy is actually due to defects in the
spk_0
proper glycosylation of a single protein called alpha-disturbed glycan.
spk_0
And so my laboratory has been working out that pathway for the last, my lab and many
spk_0
other labs around the world.
spk_0
They've been working out that pathway for the last 10 or 15 years to try to figure out
spk_0
what are the enzymes involved, what are the gene defects that lead to disease and why
spk_0
do they lead to disease.
spk_0
And so that's a lot of what my lab did.
spk_0
The other part of my lab is a mass spec lab.
spk_0
And all right, so we do a lot of mass spectrometry, kind of cutting edge, mass spectrometry.
spk_0
We've looked at things like the SARS-CoV-2 spike protein and its glycosylation and whether
spk_0
it was going to have kind of holes in the glyco shield, if you will, so that we can make
spk_0
antibodies, which of course it did.
spk_0
That's why we have vaccines because it does have holes in its shield and goodness because
spk_0
not all viruses have really big shield openings.
spk_0
During from Dr. Wells, reminds me yet again, a style important it is to understand glyco
spk_0
biology.
spk_0
You could say it's a pretty sweet science.
spk_0
Indeed it is.
spk_0
And guess what?
spk_0
It turns out, glycans aren't just the cause of many diseases.
spk_0
They can work in designing better drugs to treat them too.
spk_0
Here's Dr. Wells on glycans and therapeutics.
spk_0
See, in the treatment, right, therapeutics, it used to be almost all therapeutics were small
spk_0
molecules, right, aspirin, Tylenol, or whatever, antibiotics, right.
spk_0
But now they're biologics, right?
spk_0
So they're things like herceptin and, right, these large proteins that we're using in
spk_0
therapeutics.
spk_0
But those are glyco proteins, right?
spk_0
And so whether it's heparin that is used in every surgery on the planet, which is a big
spk_0
glycan molecule, or whether it's any of these monoclonal antibody therapies, all monoclonal
spk_0
antibodies are modified by glycans and the glycans affect, not just, you know, they affect
spk_0
their, the way they behave in terms of their half-life, how long they stick around, their
spk_0
effector function, you know, do they target ADCC, which is what sometimes you want, sometimes
spk_0
that's not what you want.
spk_0
And you can tune the glycosolation to make the antibodies do what you want them to do,
spk_0
but changing the glycosolation on them.
spk_0
Yeah.
spk_0
And I mean, even something like EPO, right, which is given to cancer patients when they're
spk_0
taking chemo, right, to keep the red blood cell counts up.
spk_0
Right.
spk_0
Ebo is a glycoprotein and it's actually a protein that we engineered to have more
spk_0
glycosolation on it because it improved the half-life of the drug.
spk_0
And so where the patient didn't have to come in every two days and get it, they could
spk_0
do it like once a week, right?
spk_0
That, you know, things like that of health.
spk_0
EPO is also that changing it from three sites to five sites is also how they test people
spk_0
for EPO in the Olympics and things like that when people drugged, right?
spk_0
So they, people use EPO to increase their red blood cell counts like bicaridates, like
spk_0
bicyclists.
spk_0
And we can catch them because the EPO that's on the market, your natural has three in-link
spk_0
glycosolation sites, but the stuff on the market has five and that's actually how they
spk_0
catch them.
spk_0
That's what they're screening for.
spk_0
The constellation really does clear rule everywhere in therapeutics, anti-coagulants to cancer
spk_0
treatment.
spk_0
I guess Mary Poppins was right to say a spoonful of sugar makes the medicine go down, or rather,
spk_0
a well-placed glycan can modify drugs to be more effective.
spk_0
Yes, Aaron, without sort of insight, Mary Poppins could have been a glyobiologist in
spk_0
disguise.
spk_0
Maybe next she'll sing to us about glycans and biofuels and remediation.
spk_0
The possibilities are truly endless.
spk_0
The collaboration that Dr. Wells is involved in doesn't just end with the CCRC.
spk_0
Let's hear from him sharing his experience working with the thought leaders in the field.
spk_0
I have the good luck that I was the person that the original geneticist reached out to
spk_0
with the OGTX linked ID.
spk_0
I mean, he could have reached out to happen to other people in the field easily.
spk_0
And then we followed up on it, right?
spk_0
And we decided to really work on and put a couple people on it.
spk_0
And that's been really rewarding.
spk_0
I really appreciate working with families.
spk_0
Obviously, I'm not a clinician.
spk_0
I can't give medical advice.
spk_0
There's nothing quite as motivating as seeing a sick child, right?
spk_0
So can I really motivate you and your lab to, you know, like, oh, maybe we ought to
spk_0
work a little harder or a little faster, right?
spk_0
So to try to help, you know, put something in the hands of people that are doing translational
spk_0
research, right?
spk_0
Because basic research leads to translational research, right?
spk_0
But all I do is what we do in the bench, how do we get it to the bedside eventually,
spk_0
right?
spk_0
And that requires a lot of people in terms of the glycobiology community.
spk_0
The field of glycobiology seems to be expanding at an exponential rate.
spk_0
With new discoveries being made on the daily, it's so exciting to imagine how much more
spk_0
progress lies ahead.
spk_0
Years Dr. Wells reflecting on some of the remarkable advancements he has witnessed and contributed
spk_0
to over the past 20 years at the CCRC.
spk_0
And the last 20 years, so many things have changed in terms of what we know scientifically.
spk_0
The tools have changed, right?
spk_0
CRISPR cast technology, gene editing, actually being able to really think about the potential
spk_0
for doing gene therapy for certain diseases, right?
spk_0
That was just off the table 20 years ago for the most part.
spk_0
In terms of atoms and the University of Georgia, I mean, I think we've benefited from having
spk_0
some amazing, probably underappreciated people in upper administration.
spk_0
I mean, I think David Lee, when he was vice president for research, changed this university.
spk_0
He really brought it up.
spk_0
I mean, it was already a research one university, but he took it to the next level.
spk_0
And that's been augmented now by Jack Hue as a servant as the provost, really pushing that.
spk_0
I think those are huge, huge things that have happened.
spk_0
And obviously the CCRC, 20 years ago, the animal part was much smaller than the plant part.
spk_0
And even though the leaders of the CCRC were plant people initially, Al Darval, Pida Bersheim,
spk_0
they had the foresight to see that they needed to grow into the biomedical realm.
spk_0
And so they brought in people like Mike TMI or myself, who then brought in people like
spk_0
Rich Steed and Lian Chun Wang and Ryan Weiss.
spk_0
And we recruited Bob Halterwanger, we recruited Jerry Art, you know, Kelly Mormon and Mike
spk_0
Pierce were already here and really kind of built up the biomedical part of the CCRC.
spk_0
So that we kind of became the big dogs in terms of funding for a long time.
spk_0
But then things shifted again, right?
spk_0
Because the biofuels, right, and remediation and using plants.
spk_0
And so there's been an expansion there.
spk_0
So now they're just two big giant groups working together.
spk_0
I think, you know, for two people leading the CCRC, they were plant people to have the
spk_0
foresight to say we need to move into the biomedical realm, even though that's way
spk_0
outside of our expertise.
spk_0
That was really brave of them.
spk_0
And they started off with a two great hires, starting with Kelly Mormon and Mike Pierce.
spk_0
And they were just able to build on that, you know, I think it's a world-class organization
spk_0
now, right?
spk_0
The extremely well-funded, you know, we've got great chemists like hurt young boons, unbelievable
spk_0
service facilities ran by Paris to a Zadi that are cutting edge, techno, you know, companies
spk_0
and labs from all over the world come to the CCRC to learn how to do glycobiology or
spk_0
send their samples here.
spk_0
That's 100% due to Paris to a Zadi being there.
spk_0
And then we've brought in people that aren't as glycophocus but are method-focused like
spk_0
in a more, right, like art, Edison.
spk_0
Of course, we have technology people like Rob Woods, Uncomputing and Run or Lando.
spk_0
And leaderships now change, right?
spk_0
And it's actually, by, by more than animal glycoballogist now, right, Mike T. Amir.
spk_0
And he's taking us in new and exciting directions, hopefully, and really trying to augment off the
spk_0
fact that the Center for Molecular Medicine is right next to the CCRC now, which is mainly
spk_0
focused on lots of stem cell differentiation, the use of stem cell technology.
spk_0
But there's so many places for the glycoballogist and the stem cell biologists to work together
spk_0
that he's really building, I think, building those relationships.
spk_0
And I think just like Pete and I were able to see the future, I think Mike's probably
spk_0
going to be able to see the future too, right?
spk_0
Pretty well.
spk_0
And it's taking the center in really exciting directions.
spk_0
It's excited to see what we've done in the last 20.
spk_0
It's going to be really exciting to see what we do in the next 20.
spk_0
So far, we've talked about Dr. Wells' research, both in the past and currently.
spk_0
But what about the future?
spk_0
What's next for him and for glycobiology?
spk_0
Well, Dr. Wells has no shortage of big ideas.
spk_0
He sees glycobiology as the future of better medicine, cleaner energy, and eco-friendly
spk_0
materials.
spk_0
We're going to have better therapeutics, better diagnostics.
spk_0
More surprised me at the plant biology people have fixed some of the recalcitrant issues
spk_0
and can really think about biofuels as a way forward to get away from fossil fuels.
spk_0
Also bio materials, I think, is an area that's really underappreciated.
spk_0
I mean, I think when everybody thinks fossil fuel, they think about gasoline.
spk_0
Everything that's made a plastic, right?
spk_0
Which is everything in our life, right?
spk_0
Most of that's coming from fossil fuel, a lot of that plastic.
spk_0
And so being able to replace that with bio materials that are A, who replace it, and B, that
spk_0
we can degrade when we're done with it, right?
spk_0
And we just doesn't end up in a landfill somewhere.
spk_0
So I was just trying to get away from this microplastic problem we're going to have.
spk_0
I wonder what we have right now and it's going to get worse.
spk_0
I think there's going to be a lot of exciting things.
spk_0
We're getting so much better at big data.
spk_0
AI is going to change the way we do things.
spk_0
The data sets we're looking at a lot of times are just so complicated that the human
spk_0
I can't see it all at one time.
spk_0
But that's something that AI can see pattern.
spk_0
You know, you can see really, really complex patterns.
spk_0
I think that's going to really help us in terms of coming up with better diagnostics,
spk_0
better therapeutics, more personalized medicine.
spk_0
I think glycobeology is going to play a major role in that, obviously.
spk_0
Obviously, that's a biased opinion, but, but yeah, I think it's highly unlikely that we
spk_0
don't play a major role in that.
spk_0
That last point about AI is so relevant right now.
spk_0
I'm excited to see how it can further glycobeology specifically, especially because
spk_0
glycobeology is so detailed with layers of sugars on proteins.
spk_0
AI might help us unlock a lot of hidden information.
spk_0
And it's amazing how Dr. Wells isn't just thinking about the future in terms of science,
spk_0
but also the next generation of scientists.
spk_0
So mentoring and just helping the next generation has always been really important to me.
spk_0
I was the graduate coordinator for biochemistry department here for 10 years.
spk_0
And then after that, I was the director of Integrated Life Science, which is kind of the
spk_0
large umbrella program that all life science graduate students come in.
spk_0
I ran that for five years and I've had 18 people in my lab get their PhDs in my lab.
spk_0
I've got eight graduate students in my lab right now.
spk_0
I always have undergrad in my lab right now.
spk_0
I've had undergrad set of right, we've had two when the gold water, we've had people graduate
spk_0
with their medical degrees from Hopkins and Stanford and University of Florida, you know,
spk_0
all over the place.
spk_0
And you know, just training the next generation.
spk_0
Yeah, actually having young people in the lab helps keep me young.
spk_0
Because the thing is sometimes as you get older, you have so much dogma that you've learned
spk_0
that young people will do experiments that I would never do because I'd be like, oh,
spk_0
that's not going to work.
spk_0
And they don't know that it shouldn't work, right?
spk_0
But then everyone's probably works, right?
spk_0
And the challenge is the dogma.
spk_0
And so I think a lot of great ideas can come out of young people.
spk_0
That part where he said young people don't know what should or shouldn't work.
spk_0
So they just try everything.
spk_0
I love that.
spk_0
Name, it's such a great reminder that science needs fresh perspectives.
spk_0
For the young listeners who are interested in or just starting research,
spk_0
a mistake could very well be a scientific breakthrough.
spk_0
You never know.
spk_0
He's really made mentorship a priority.
spk_0
His lab has trained so many students who've gone on to do incredible things.
spk_0
Terilin Bertosi said it a lot better than I ever could when the Nobel Prize a couple years ago.
spk_0
Is right?
spk_0
Our job as scientists is not to try to be famous, not give rich,
spk_0
to train the next generation and make new discoveries.
spk_0
And all of that's going to outlive us.
spk_0
That's how as a scientist, you make yourself immortal, right?
spk_0
It is by passing on the knowledge to the next generation.
spk_0
So I've gotten a lot of pleasure out of doing that.
spk_0
I like working with young people.
spk_0
They have ideas and thoughts that aren't sometimes burned by knowledge.
spk_0
Right?
spk_0
Just because they're not, because they're not smart,
spk_0
just because they just haven't been exposed to it yet.
spk_0
And so they can come up with some really clever ways of thinking about stuff.
spk_0
Right?
spk_0
It helps keep our ideas fresh.
spk_0
Right in the lab, which is important.
spk_0
Scientific immortality is such a powerful way to think about teaching and research.
spk_0
I know, right?
spk_0
The people that have helped me and my science and personal journey have changed my life.
spk_0
I'm so sure Dr. Wells has had the same exact impact on so many people.
spk_0
So true.
spk_0
And it's not just about mentoring within the lab.
spk_0
He's also thinking about the bigger picture,
spk_0
like with the massive NSF Great Grant his team received.
spk_0
$18 million over six years.
spk_0
Most recently we just got a grant that on PIA from the National Science Foundation,
spk_0
what are called Bio-Foundaries that they just got established.
spk_0
And so our UGA grant is for $18 million over six years.
spk_0
It's called Bio-F Great and Great stands for Glycoscience Research Education and Training.
spk_0
And so the idea is that like we said at the very beginning of the stock,
spk_0
a lot of people understand proteins, they understand nucleic acids,
spk_0
but they don't understand carbohydrates very well.
spk_0
And so we're going to be working with high school teachers to kind of inform them.
spk_0
We're going to be developing undergraduate material, graduate material.
spk_0
And we're also going to be developing research tools to make it easier to study in the lab.
spk_0
So the whole idea is that glycobiology as a field is under taught in the classroom and under
spk_0
studied in the research laboratory.
spk_0
And so we're going to try to bridge that problem and see if we can provide tools
spk_0
to help it be taught more effectively and more broadly.
spk_0
And for making it easier to study at the bench for labs that aren't, you know, glyco-fabe focus labs.
spk_0
It's kind of wild how under taught glycobiology is, considering how much of our biology it affects.
spk_0
Exactly. I love how he's pushing this knowledge both inside and outside of the lab.
spk_0
I would have loved to learn about this in high school.
spk_0
Me too. No one should have to wait until a PhD to learn about sugars doing all this cool stuff.
spk_0
And if you're someone who is just starting your science journey, I am sure Dr. Wells has some
spk_0
pretty solid advice. I've got to tell you a couple of different things. One is you should do
spk_0
things you love doing. If you're doing something repetitively, right, whether that's graduate school
spk_0
or working in a job, right? You know, if you realize you're waking up every day not wanting to go to
spk_0
that job, you're doing the wrong job. Now, sometimes you don't have a choice in life, right?
spk_0
Sometimes you're not fortunate enough that usually in graduate school, you're fortunate.
spk_0
I tell people if they're not happy in the lab they're in, there's one or two possibilities,
spk_0
either in the wrong lab that chose the wrong mentor or be they're not supposed to be in a lab,
spk_0
and they should go do something else with their life and be productive and happy.
spk_0
I find that people who are enthusiastic and love what they do have a tendency to be really good at.
spk_0
I don't know many people that are really good at things they dislike doing.
spk_0
And so, you know, the other thing I always tell grad students when I was a director is,
spk_0
right, look around the room, everybody's smart, right? Everybody's smart. And so, are you
spk_0
enthusiastic or are you doing what you want to do and are you willing to put in the effort to get
spk_0
it done? You know, unfortunately, there's only so many hours in the day and graduate school
spk_0
takes a lot of those, right? And being a scientist, you know, I kind of wake up thinking about science,
spk_0
I kind of go to bed thinking about science of the back of my head, you know, Thanksgiving dinner,
spk_0
I'm like, well, you know, some pops in my head, right? And that's not to say I don't have a social
spk_0
life and that, you know, there's not a work-life balance. But you find that things that you're really
spk_0
passionate about and you love, you kind of think about all the time, right? What I wish for people
spk_0
is they find, whether that's being a scientist or being something else, is they find a job that's
spk_0
rewarding to them as my job is to me. Working together to try to revolutionize how we teach and how
spk_0
we do research on lack of biology. That idea of waking up every day excited to go to work,
spk_0
I hope we can all find that in our future careers, whatever we do. passion really does make the
spk_0
difference. Yes, sometimes people feel stuck in a role they have because they've already started
spk_0
down the path. Dr. Walls makes it clear that if you don't love what you're doing, it's okay to
spk_0
pivot. Definitely. Dr. Wells shows us that you can go above and beyond in any field you do.
spk_0
Science is just as much about people as it is about discovery. And with leaders like him in the field,
spk_0
the feature of glycobiology is looking pretty bright. Leader, if you will.
spk_0
Thank you for listening to Let's Talk Chemistry, a podcast by KempTalk. We hope you enjoyed it.
spk_0
For more information on today's episode in countless chemistry resources, please visit our website at www.chemistrytalk.org.